Kwivik Therapeutics Receives Market Clearance for O2Ventilate in India
Frisco, Texas, July 07, 2021 (GLOBE NEWSWIRE) -- Kwivik Therapeutics Inc (Kwivik), a medtech developer of disruptive technologies for respiratory and emergency medical markets today announced the Company has received market clearance for its O2Ventilate product from the Ministry of Health in India.
- Frisco, Texas, July 07, 2021 (GLOBE NEWSWIRE) -- Kwivik Therapeutics Inc (Kwivik), a medtech developer of disruptive technologies for respiratory and emergency medical markets today announced the Company has received market clearance for its O2Ventilate product from the Ministry of Health in India.
- O2Ventilate is a Manual Emergency Ventilator system intended for the emergency, non-invasive ventilation of children and adults.
- The O2Ventilate device is intended for use by trained responders to manually provide emergency ventilation to a patient when a mechanical ventilator is not immediately available due to the COVID19 pandemic.
- We are very pleased to advance the earnest work of making a difference in the fight against COVID19 in India, as well as the rest of the world, said Julian Ross, CEO of Kwivik Therapeutics.